COVID-19 Oxford Vaccine Trial

The Oxford Vaccine Centre’s COVID-19 vaccine trial is being…

Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

Cambridge University Hospitals has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.

INCLUDE, making health research more inclusive

The NIHR Clinical Research Network (CRN) INCLUDE steering group, following discussions with key stakeholders, ongoing research and hosting a series of events, are delighted to have developed new guidance.

Rapid Covid testing results published

April 2020, research staff from NIHR Cambridge Clinical Research Facility were deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a research trial to diagnose COVID-19.

What are the after effects of Coronavirus?

Addenbrooke’s has set up a number of clinics to specifically help patients address any ongoing health issues, one of the clinics is the Complex Covid Multi-Disciplinary Team (MDT) clinic for patients with complex needs who need to be seen by two or more specialities, such as a neurologist or a respiratory consultant.

Cytosponge and BEST 3 Trial feature on Look East

A ‘pill on a string’ pill test can identify ten times more people with Barrett’s Oesophagus than the current usual GP route, according to a new study funded by Cancer Research UK and published this week in The Lancet.

Nature’s epidural: Genetic variant may explain why some women don’t need pain relief during childbirth

Women who do not need pain relief during childbirth may be carriers of a key genetic variant that acts a natural epidural, say scientists at the University of Cambridge.

Sponge on a string test to transform oesophageal cancer diagnosis

A ‘sponge on a string’ pill test can identify ten times more people with Barrett’s oesophagus than the usual GP route, according to a new study funded by Cancer Research UK and published in The Lancet.

Dr Estee Török on tackling Covid-19

Dr Estee Török, is a Honorary Consultant in infectious Diseases and Microbiology and Principal Investigator at Cambridge University Hospital, talks about her experiences and passion for infectious diseases and leading a novel coronavirus vaccine 'COV002’ trial, in Cambridge.